US Stock MarketDetailed Quotes

TXG 10x Genomics

Watchlist
  • 13.290
  • -0.030-0.23%
Close Nov 21 16:00 ET
1.61BMarket Cap-8743P/E (TTM)

10x Genomics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
185.52%21.64M
165.04%7.5M
-281.21%-15.73M
54.78%-15.2M
87.70%25.76M
-164.58%-25.3M
32.05%-11.53M
80.17%-4.13M
-57.24%-33.61M
136.40%13.72M
Net income from continuing operations
61.55%-35.75M
39.28%-37.9M
-18.13%-59.95M
-53.67%-255.1M
-184.36%-48.95M
-121.85%-92.99M
3.17%-62.41M
-19.65%-50.75M
-185.11%-166M
6.69%-17.22M
Operating gains losses
--2K
----
----
--1.72M
--3K
--0
--0
--1.72M
----
----
Depreciation and amortization
-5.87%10.75M
-8.23%10.9M
33.40%11.49M
32.15%43.62M
38.17%11.71M
40.73%11.42M
40.66%11.88M
8.04%8.62M
16.82%33.01M
15.67%8.47M
Other non cash items
----
----
196.00%444K
----
----
----
----
-18.03%150K
----
----
Change In working capital
-19.65%12.99M
59.08%-4.07M
-5.65%-6.3M
144.00%17.34M
188.22%17.07M
262.69%16.17M
-503.62%-9.93M
52.68%-5.96M
54.92%-39.42M
-93.70%-19.35M
-Change in receivables
147.53%7.68M
101.25%122K
-10.51%23.52M
43.99%-10.61M
46.78%-10.97M
-119.87%-16.17M
-3,383.84%-9.75M
201.09%26.28M
44.34%-18.95M
-202.14%-20.62M
-Change in inventory
-265.97%-4.26M
-179.11%-5.2M
-2,113.14%-9.94M
137.14%7.87M
632.08%7.61M
129.65%2.57M
74.72%-1.86M
87.98%-449K
29.67%-21.19M
83.71%-1.43M
-Change in prepaid assets
204.66%1.59M
-46.90%1.13M
52.29%-2.03M
45.96%-2.43M
159.72%1.22M
-152.68%-1.52M
244.41%2.13M
-9.81%-4.25M
-326.88%-4.5M
-1,320.36%-2.04M
-Change in payables and accrued expense
-114.76%-669K
-39.31%1.67M
-758.92%-8.09M
142.38%22.28M
6,406.94%15.94M
25.63%4.53M
-54.21%2.75M
-41.44%-942K
127.07%9.19M
-56.64%245K
-Change in other current assets
-98.41%283K
69.10%-2.35M
102.06%216K
-173.30%-678K
-175.49%-388K
5,907.77%17.78M
-18,002.38%-7.6M
-6,768.79%-10.47M
-11.48%925K
-26.26%514K
-Change in other current liabilities
-315.17%-3.83M
-14.61%-2.57M
-32.49%-2.71M
21.12%-7.39M
-20.94%-2.17M
83.93%-923K
-34.19%-2.25M
-1,255.63%-2.05M
-30.54%-9.37M
-203.89%-1.8M
-Change in other working capital
23.23%12.2M
-52.90%3.13M
48.43%-7.26M
85.82%8.3M
0.78%5.83M
97.05%9.9M
-0.94%6.65M
-7.85%-14.08M
-75.02%4.46M
20.89%5.78M
Cash from discontinued investing activities
Operating cash flow
185.52%21.64M
165.04%7.5M
-281.21%-15.73M
54.78%-15.2M
87.70%25.76M
-164.58%-25.3M
32.05%-11.53M
80.17%-4.13M
-57.24%-33.61M
136.40%13.72M
Investing cash flow
Cash flow from continuing investing activities
-173.84%-3.62M
367.75%11.95M
-91.14%10.63M
138.04%133.49M
139.49%13.1M
115.02%4.9M
83.79%-4.46M
146.57%119.96M
-228.76%-350.89M
-20.11%-33.17M
Net PPE purchase and sale
74.47%-3.89M
88.65%-2.88M
36.17%-2.91M
63.09%-48.6M
91.32%-3.45M
58.34%-15.24M
6.84%-25.36M
83.80%-4.56M
-30.00%-131.66M
-43.87%-39.73M
Net intangibles purchase and sale
--0
---1M
--0
---923K
--0
---200K
--0
---723K
--0
--0
Net business purchase and sale
----
----
----
--0
----
----
----
----
26.62%-4M
---2.5M
Net investment purchase and sale
-98.67%271K
-24.26%15.83M
-89.19%13.54M
185.03%183.02M
82.61%16.55M
273.69%20.34M
6,883.77%20.89M
154.59%125.24M
---215.23M
--9.06M
Cash from discontinued investing activities
Investing cash flow
-173.84%-3.62M
367.75%11.95M
-91.14%10.63M
138.04%133.49M
139.49%13.1M
115.02%4.9M
83.79%-4.46M
146.57%119.96M
-228.76%-350.89M
-20.11%-33.17M
Financing cash flow
Cash flow from continuing financing activities
-96.43%156K
-35.13%4.6M
147.98%1.64M
-13.58%13.67M
12.24%5.61M
114.52%4.37M
11.57%7.1M
-241.25%-3.41M
-55.19%15.82M
-43.83%5M
Proceeds from stock option exercised by employees
-96.43%156K
-35.13%4.6M
-31.75%1.64M
-8.21%19.48M
12.24%5.61M
114.52%4.37M
11.57%7.1M
-69.33%2.4M
-47.36%21.23M
-43.83%5M
Net other financing activities
----
----
----
-7.49%-5.81M
--0
--0
--0
-7.49%-5.81M
-7.58%-5.41M
--0
Cash from discontinued financing activities
Financing cash flow
-96.43%156K
-35.13%4.6M
147.98%1.64M
-13.58%13.67M
12.24%5.61M
114.52%4.37M
11.57%7.1M
-241.25%-3.41M
-55.19%15.82M
-43.83%5M
Net cash flow
Beginning cash position
14.80%379.82M
4.70%355.78M
58.03%359.28M
-61.86%227.35M
30.30%314.74M
17.41%330.85M
6.15%339.79M
-61.86%227.35M
-13.44%596.07M
-60.34%241.55M
Current changes in cash
213.41%18.18M
370.42%24.05M
-103.07%-3.46M
135.79%131.96M
407.79%44.47M
60.08%-16.03M
76.68%-8.89M
140.74%112.42M
-297.26%-368.68M
-11.91%-14.45M
Effect of exchange rate changes
283.53%156K
93.88%-3K
-300.00%-48K
25.00%-33K
-69.32%77K
0.00%-85K
74.48%-49K
233.33%24K
-118.80%-44K
406.10%251K
End cash Position
26.50%398.16M
14.80%379.82M
4.70%355.78M
58.03%359.28M
58.03%359.28M
30.30%314.74M
17.41%330.85M
6.15%339.79M
-61.86%227.35M
-61.86%227.35M
Free cash flow
143.57%17.75M
109.81%3.62M
-98.10%-18.64M
60.84%-64.72M
185.76%22.31M
11.70%-40.74M
16.52%-36.88M
80.78%-9.41M
-34.75%-165.27M
-19.25%-26.01M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 185.52%21.64M165.04%7.5M-281.21%-15.73M54.78%-15.2M87.70%25.76M-164.58%-25.3M32.05%-11.53M80.17%-4.13M-57.24%-33.61M136.40%13.72M
Net income from continuing operations 61.55%-35.75M39.28%-37.9M-18.13%-59.95M-53.67%-255.1M-184.36%-48.95M-121.85%-92.99M3.17%-62.41M-19.65%-50.75M-185.11%-166M6.69%-17.22M
Operating gains losses --2K----------1.72M--3K--0--0--1.72M--------
Depreciation and amortization -5.87%10.75M-8.23%10.9M33.40%11.49M32.15%43.62M38.17%11.71M40.73%11.42M40.66%11.88M8.04%8.62M16.82%33.01M15.67%8.47M
Other non cash items --------196.00%444K-----------------18.03%150K--------
Change In working capital -19.65%12.99M59.08%-4.07M-5.65%-6.3M144.00%17.34M188.22%17.07M262.69%16.17M-503.62%-9.93M52.68%-5.96M54.92%-39.42M-93.70%-19.35M
-Change in receivables 147.53%7.68M101.25%122K-10.51%23.52M43.99%-10.61M46.78%-10.97M-119.87%-16.17M-3,383.84%-9.75M201.09%26.28M44.34%-18.95M-202.14%-20.62M
-Change in inventory -265.97%-4.26M-179.11%-5.2M-2,113.14%-9.94M137.14%7.87M632.08%7.61M129.65%2.57M74.72%-1.86M87.98%-449K29.67%-21.19M83.71%-1.43M
-Change in prepaid assets 204.66%1.59M-46.90%1.13M52.29%-2.03M45.96%-2.43M159.72%1.22M-152.68%-1.52M244.41%2.13M-9.81%-4.25M-326.88%-4.5M-1,320.36%-2.04M
-Change in payables and accrued expense -114.76%-669K-39.31%1.67M-758.92%-8.09M142.38%22.28M6,406.94%15.94M25.63%4.53M-54.21%2.75M-41.44%-942K127.07%9.19M-56.64%245K
-Change in other current assets -98.41%283K69.10%-2.35M102.06%216K-173.30%-678K-175.49%-388K5,907.77%17.78M-18,002.38%-7.6M-6,768.79%-10.47M-11.48%925K-26.26%514K
-Change in other current liabilities -315.17%-3.83M-14.61%-2.57M-32.49%-2.71M21.12%-7.39M-20.94%-2.17M83.93%-923K-34.19%-2.25M-1,255.63%-2.05M-30.54%-9.37M-203.89%-1.8M
-Change in other working capital 23.23%12.2M-52.90%3.13M48.43%-7.26M85.82%8.3M0.78%5.83M97.05%9.9M-0.94%6.65M-7.85%-14.08M-75.02%4.46M20.89%5.78M
Cash from discontinued investing activities
Operating cash flow 185.52%21.64M165.04%7.5M-281.21%-15.73M54.78%-15.2M87.70%25.76M-164.58%-25.3M32.05%-11.53M80.17%-4.13M-57.24%-33.61M136.40%13.72M
Investing cash flow
Cash flow from continuing investing activities -173.84%-3.62M367.75%11.95M-91.14%10.63M138.04%133.49M139.49%13.1M115.02%4.9M83.79%-4.46M146.57%119.96M-228.76%-350.89M-20.11%-33.17M
Net PPE purchase and sale 74.47%-3.89M88.65%-2.88M36.17%-2.91M63.09%-48.6M91.32%-3.45M58.34%-15.24M6.84%-25.36M83.80%-4.56M-30.00%-131.66M-43.87%-39.73M
Net intangibles purchase and sale --0---1M--0---923K--0---200K--0---723K--0--0
Net business purchase and sale --------------0----------------26.62%-4M---2.5M
Net investment purchase and sale -98.67%271K-24.26%15.83M-89.19%13.54M185.03%183.02M82.61%16.55M273.69%20.34M6,883.77%20.89M154.59%125.24M---215.23M--9.06M
Cash from discontinued investing activities
Investing cash flow -173.84%-3.62M367.75%11.95M-91.14%10.63M138.04%133.49M139.49%13.1M115.02%4.9M83.79%-4.46M146.57%119.96M-228.76%-350.89M-20.11%-33.17M
Financing cash flow
Cash flow from continuing financing activities -96.43%156K-35.13%4.6M147.98%1.64M-13.58%13.67M12.24%5.61M114.52%4.37M11.57%7.1M-241.25%-3.41M-55.19%15.82M-43.83%5M
Proceeds from stock option exercised by employees -96.43%156K-35.13%4.6M-31.75%1.64M-8.21%19.48M12.24%5.61M114.52%4.37M11.57%7.1M-69.33%2.4M-47.36%21.23M-43.83%5M
Net other financing activities -------------7.49%-5.81M--0--0--0-7.49%-5.81M-7.58%-5.41M--0
Cash from discontinued financing activities
Financing cash flow -96.43%156K-35.13%4.6M147.98%1.64M-13.58%13.67M12.24%5.61M114.52%4.37M11.57%7.1M-241.25%-3.41M-55.19%15.82M-43.83%5M
Net cash flow
Beginning cash position 14.80%379.82M4.70%355.78M58.03%359.28M-61.86%227.35M30.30%314.74M17.41%330.85M6.15%339.79M-61.86%227.35M-13.44%596.07M-60.34%241.55M
Current changes in cash 213.41%18.18M370.42%24.05M-103.07%-3.46M135.79%131.96M407.79%44.47M60.08%-16.03M76.68%-8.89M140.74%112.42M-297.26%-368.68M-11.91%-14.45M
Effect of exchange rate changes 283.53%156K93.88%-3K-300.00%-48K25.00%-33K-69.32%77K0.00%-85K74.48%-49K233.33%24K-118.80%-44K406.10%251K
End cash Position 26.50%398.16M14.80%379.82M4.70%355.78M58.03%359.28M58.03%359.28M30.30%314.74M17.41%330.85M6.15%339.79M-61.86%227.35M-61.86%227.35M
Free cash flow 143.57%17.75M109.81%3.62M-98.10%-18.64M60.84%-64.72M185.76%22.31M11.70%-40.74M16.52%-36.88M80.78%-9.41M-34.75%-165.27M-19.25%-26.01M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data